TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07104279: Z1 Hip System: Post-Market Clinical Follow Up Study

Sponsor: Zimmer Biomet · Phase: PHASE2 · Area: IMMUNOLOGY · Target Enrollment: 300 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$11,040,000

Rescue Site Savings

+$7,279,500

Unlock Full NCT07104279 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07104279 Rescue Dossier →